pharma QA findings – SOP Guide for Pharma https://www.pharmasop.in The Ultimate Resource for Pharmaceutical SOPs and Best Practices Sat, 22 Nov 2025 04:51:14 +0000 en-US hourly 1 Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard https://www.pharmasop.in/technicians-using-outdated-laminated-sops-a-gmp-documentation-hazard/ Thu, 28 Aug 2025 08:16:32 +0000 https://www.pharmasop.in/?p=13636 Read More “Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard” »

]]>
Technicians Using Outdated Laminated SOPs: A GMP Documentation Hazard

How Laminated SOPs Lead to GMP Non-Compliance on the Shop Floor

Introduction to the Audit Finding

1. Audit Concern

Technicians rely on laminated hardcopies of SOPs that are not updated or recalled after revisions. These outdated versions remain in active use.

2. GMP Risk

  • Old procedures may differ from current validated steps
  • Operators unknowingly follow obsolete instructions
  • Deviations go undetected until quality or regulatory review

3. Where It Happens

Common in maintenance, cleaning, and calibration activities — especially in areas where laminated or wall-mounted SOPs are preferred for convenience.

4. Case Example

During a GMP audit, a technician was found referring to a laminated cleaning SOP that had been revised three months earlier. The updated procedure introduced a new disinfectant contact time, which was missed.

Regulatory Expectations and Inspection Observations

1. USFDA 21 CFR 211.100(a)

Procedures must be in writing and followed — and the current version must be used at all times.

2. EU GMP Chapter 4.3

Requires controlled distribution of documents and withdrawal of obsolete versions from all locations.

3. WHO TRS 986

Stipulates that printed SOPs should be clearly controlled and reviewed periodically for version integrity.

4. Regulatory Findings

  • FDA 483: “Outdated laminated SOPs were observed posted in the equipment maintenance room.”
  • EMA: “SOP versions displayed in production did not match the master controlled copy.”

Root Causes of Outdated Laminated SOP Use

1. Lack of Retrieval Mechanism

No defined process to collect or destroy old laminated SOPs when a new version is released.

2. Informal SOP Distribution

Laminated copies often distributed by floor supervisors without coordination with QA or document control.

3. Misconception of Utility

Belief that laminated SOPs are a “permanent reference” and do not need frequent updates.

4. Inadequate Training

Technicians unaware of the risk posed by referencing physical SOPs outside controlled systems.

Prevention of SOP Outdating via Laminated Use

1. Prohibit Laminated SOPs for Critical Activities

Implement policy disallowing use of laminated SOPs in GMP-critical areas like cleaning, maintenance, calibration.

2. SOP Withdrawal Checklist

QA to maintain a log of where laminated copies are used and include retrieval as part of SOP revision rollout.

3. Central Controlled Access

Direct staff to refer to digital SOPs via controlled terminals or tablets with version access control.

4. Physical Stamp or QR Code System

Print SOPs with “VALID TILL” date or embed scannable codes to verify real-time version status.

5. Maintenance Team Alignment

Train maintenance staff specifically on SOP change notification and immediate document substitution practices.

Corrective and Preventive Actions (CAPA)

1. Corrective Measures

  • Immediately identify and remove all laminated SOPs across facility
  • Cross-check currently used procedures against the QA-controlled master
  • Communicate policy update to all relevant departments

2. Preventive Controls

Revise the Documentation Control SOP to include laminated SOP distribution/withdrawal control, and version verification tracking.

3. Audit and Spot Checks

Include laminated SOP usage check in internal audit program with documentation of findings and follow-up.

4. Governance Through Technology

Introduce SOP access validation through Stability testing portals or GMP software tools.

5. Regulatory Reference

Align SOP governance with ANVISA and USFDA expectations on documentation traceability and current version access.

]]>